Effectiveness of Kinesiologic Taping and Dry Needling in the Treatment of Subacromial Pain Syndrome

NCT07190768 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-09-24

No results posted yet for this study

Summary

This study aims to compare the effectiveness of two common physiotherapy methods, Kinesiologic Taping (KT) and Dry Needling (DN), in the treatment of Subacromial Pain Syndrome (SAPS), a frequent cause of shoulder pain. The trial also investigates whether using KT and DN together provides greater benefits than using them separately. The main goal is to determine which treatment approach is more effective in reducing pain and improving shoulder function in patients with SAPS.

Conditions

  • Shoulder Pain
  • Shoulder Impingement Syndrome

Interventions

OTHER

Kinesio Taping

Participants received Kinesio Taping (KT) applied to the affected shoulder using standard 5-cm Kinesio Tex tape. Before application, an allergy test was performed by placing a small patch of tape on the contralateral forearm for 15 minutes. The taping procedure included three regions: supraspinatus muscle, deltoid muscle, and glenohumeral joint. Application technique: Supraspinatus: Y-strip applied from insertion on the greater tubercle along the muscle to its origin with 20-25% stretch. Deltoid: Y-strip applied from 3 cm below insertion to the origin, with anterior and posterior tails placed along corresponding edges. Glenohumeral joint: I-strip applied from the coracoid process, laterally under the acromion, around the posterior deltoid edge. Schedule: Tape was applied at baseline (Day 0), reapplied at Day 7, and removed permanently at Day 14.

OTHER

Dry Needling

Participants received dry needling (DN) applied with sterile, disposable stainless-steel needles (0.30 mm × 50 mm). Target muscles included the supraspinatus, deltoideus, infraspinatus, subscapularis, and pectoralis major. Technique: The "fast-in, fast-out" method (Hong technique) was used. After cleaning the skin with alcohol, the needle was inserted into a palpable taut band until the first local twitch response (LTR) was elicited. The needle was moved vertically (5-10 mm) at \~1 Hz for 25-30 seconds. DN was applied for 45-60 seconds per muscle. Schedule: Twice per week, for 3 weeks (total of 6 sessions).

BEHAVIORAL

Exercise Program

All participants were instructed in a standardized home-based exercise program designed to improve shoulder mobility and stability. Content: Exercises included active range-of-motion movements, scapular stabilization, and strengthening of rotator cuff and periscapular muscles. Ergonomic advice and posture correction were also provided. Delivery: Participants were taught the program in person and instructed to perform the exercises at home. Schedule: Exercises were performed daily for 3 weeks, in addition to the assigned intervention for each study arm.

DEVICE

Conventional Physical Therapy (TENS/Ultrasound/Heat pack)

Participants in this arm received conventional physical therapy modalities commonly used for the management of subacromial pain syndrome. Modalities: Transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, or superficial heat pack were applied based on standard clinical practice. Additional care: Sessions also included passive mobilization of the shoulder into end range, scapular stabilization exercises, and ergonomic/postural advice. Schedule: One-hour treatment sessions, 5 days per week, for 3 consecutive weeks.

Sponsors & Collaborators

  • Bursa City Hospital

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-01-01
Completion
2026-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07190768 on ClinicalTrials.gov